Style | Citing Format |
---|---|
MLA | Rahmati M, Moosavi MA. "Cytokine-Targeted Therapy in Severely Ill Covid-19 Patients: Options and Cautions." Eurasian Journal of Medicine and Oncology, vol. 4, no. 2, 2020, pp. 179-180. |
APA | Rahmati M, Moosavi MA (2020). Cytokine-Targeted Therapy in Severely Ill Covid-19 Patients: Options and Cautions. Eurasian Journal of Medicine and Oncology, 4(2), 179-180. |
Chicago | Rahmati M, Moosavi MA. "Cytokine-Targeted Therapy in Severely Ill Covid-19 Patients: Options and Cautions." Eurasian Journal of Medicine and Oncology 4, no. 2 (2020): 179-180. |
Harvard | Rahmati M, Moosavi MA (2020) 'Cytokine-Targeted Therapy in Severely Ill Covid-19 Patients: Options and Cautions', Eurasian Journal of Medicine and Oncology, 4(2), pp. 179-180. |
Vancouver | Rahmati M, Moosavi MA. Cytokine-Targeted Therapy in Severely Ill Covid-19 Patients: Options and Cautions. Eurasian Journal of Medicine and Oncology. 2020;4(2):179-180. |
BibTex | @article{ author = {Rahmati M and Moosavi MA}, title = {Cytokine-Targeted Therapy in Severely Ill Covid-19 Patients: Options and Cautions}, journal = {Eurasian Journal of Medicine and Oncology}, volume = {4}, number = {2}, pages = {179-180}, year = {2020} } |
RIS | TY - JOUR AU - Rahmati M AU - Moosavi MA TI - Cytokine-Targeted Therapy in Severely Ill Covid-19 Patients: Options and Cautions JO - Eurasian Journal of Medicine and Oncology VL - 4 IS - 2 SP - 179 EP - 180 PY - 2020 ER - |